Overview
A deal is one biopharma transaction: an acquisition, merger, asset purchase, licensing agreement, collaboration, option, joint venture or distribution agreement. Each deal keeps one stabledeal_id as new filings and releases
report on it, and carries its parties, its headline economics, its lifecycle
from proposal to completion or termination, and the source documents behind
every term.
Questions this dataset answers:
- What are the largest biopharma acquisitions by headline value?
- Which deals has Eli Lilly done this year, and on what terms?
- Which licensing deals were announced since January, and for which rights?
- Where does a stated upfront or milestone figure come from?
Coverage
Many deals disclose no value.
min_value_usd and sort=headline_value only
consider deals with a stated USD headline value.
Key fields
GET /v1/deals/{deal_id} adds terms (headline value, upfront, equity,
milestones, royalties, territories, rights), events[] with the source URL of
each lifecycle step, and source_documents[].
Endpoints
Filters
All filters are optional and combine with AND. With no filters you get the most recent deal activity.Largest deals
Example response (trimmed)
A company’s deals
Example response (trimmed)
Get one deal with terms and sources
Example response (trimmed)
Related
- Deal screening guide
- Companies: resolve a party name to
company_id.